Income Statement Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Market Closed - Euronext Paris Other stock markets 11:35:17 2025-01-14 am EST			5-day change	1st Jan Change
46.08 ^EUR	-5.98%		-7.21%	-6.55%

Dec. 23	Eurofins: 4th share buyback program	CF
Nov. 28	EUROFINS SCIENTIFIC : NAV cut by -6.0%

3b61c73e1c2f37344f38a4ca36066.HOLne0oUfmRzhTpejqxoRx6ECwki3i4BaaH5MHgtIWM.frKmLnlHNQs60AIvuvwwHSbgX09TjGd2Nu_BYk9aRyBNmIQNMnhLEALdCg

Published financial data: EUROFINS SCIENTIFIC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	4.56B	5.44B	6.72B	6.71B	6.51B
Total Revenues	4.56B	5.44B	6.72B	6.71B	6.51B
Cost of Goods Sold, Total	3.63B	4.03B	4.8B	5.19B	5.14B
Gross Profit	931M	1.41B	1.91B	1.53B	1.37B
Selling General & Admin Expenses, Total	1M	600K	12.8M	14.2M	13.1M
Stock-Based Compensation (IS)	116M	119M	120M	127M	123M
Depreciation & Amortization - (IS)	357M	389M	429M	476M	522M
Other Operating Expenses, Total	474M	508M	562M	618M	658M
Operating Income	456M	904M	1.35B	909M	717M
Interest Expense, Total	-96.5M	-103M	-94.3M	-91.6M	-123M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-96.5M	-103M	-94.3M	-91.6M	-123M
Income (Loss) On Equity Invest.	600K	1.7M	2M	900K	400K
Currency Exchange Gains (Loss)	-2.9M	-4.7M	-17.9M	-32.9M	11.2M
Other Non Operating Income (Expenses)	4.7M	500K	1.8M	-11.6M	7.2M
EBT, Excl. Unusual Items	362M	799M	1.24B	774M	612M
Restructuring Charges	-48M	-53.5M	-32.2M	-	-
Merger & Related Restructuring Charges	-8.3M	-6.2M	-13.6M	-8.7M	-15.1M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	141M	-1.8M
Other Unusual Items	-34.5M	-44.9M	-142M	-126M	-172M
EBT, Incl. Unusual Items	272M	694M	1.06B	780M	423M
Income Tax Expense	76.3M	154M	274M	174M	116M
Earnings From Continuing Operations	195M	540M	783M	606M	308M
Net Income to Company	195M	540M	783M	606M	308M
Minority Interest	-	-1M	-400K	4.4M	2.5M
Net Income - (IS)	195M	539M	783M	610M	310M
Preferred Dividend and Other Adjustments	49.7M	34.1M	34.1M	29.3M	53.7M
Net Income to Common Incl Extra Items	146M	505M	748M	581M	256M
Net Income to Common Excl. Extra Items	146M	505M	748M	581M	256M
Per Share Items
Net EPS - Basic	0.82	2.71	3.91	3.02	1.33
Basic EPS - Continuing Operations	0.82	2.71	3.91	3.02	1.33
Basic Weighted Average Shares Outstanding	178M	186M	192M	192M	193M
Net EPS - Diluted	0.78	2.58	3.73	2.92	1.3
Diluted EPS - Continuing Operations	0.78	2.58	3.73	2.92	1.3
Diluted Weighted Average Shares Outstanding	186M	196M	201M	199M	198M
Normalized Basic EPS	1.27	2.68	4.06	2.53	2
Normalized Diluted EPS	1.22	2.54	3.87	2.45	1.95
Dividend Per Share	0.34	0.68	1	1	0.5
Payout Ratio	61.27	6.73	21.22	37.36	75.4
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	803M	1.27B	1.75B	1.35B	1.19B
EBITA	556M	1.01B	1.45B	1.01B	816M
EBIT	456M	904M	1.35B	909M	717M
EBITDAR	-	1.29B	1.76B	1.37B	1.2B
Effective Tax Rate - (Ratio)	28.1	22.17	25.89	22.33	27.29
Total Current Taxes	92.5M	169M	300M	201M	157M
Total Deferred Taxes	-16.3M	-15.4M	-26.3M	-27M	-41.4M
Normalized Net Income	226M	498M	777M	488M	385M
Interest on Long-Term Debt	75.6M	84.9M	72.7M	76.3M	106M
Non-Cash Pension Expense	700K	-400K	500K	400K	2.2M
Supplemental Operating Expense Items
Net Rental Expense, Total	-	16.8M	12.1M	13.4M	11M
Imputed Operating Lease Interest Expense	-	4.13M	3.09M	3.23M	2.99M
Imputed Operating Lease Depreciation	-	12.67M	9.01M	10.17M	8.01M
Stock-Based Comp., Other (Total)	116M	119M	120M	127M	123M
Total Stock-Based Compensation	116M	119M	120M	127M	123M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	297M	912M	515M	487M	1.22B
Trading Asset Securities, Total	300K	100K	500K	5.6M	4.3M
Total Cash And Short Term Investments	297M	912M	516M	492M	1.23B
Accounts Receivable, Total	1B	1.19B	1.39B	1.34B	1.38B
Other Receivables	184M	196M	192M	256M	236M
Total Receivables	1.19B	1.39B	1.58B	1.6B	1.62B
Inventory	79.3M	157M	154M	146M	139M
Prepaid Expenses	42.5M	59.6M	68M	78.3M	84.9M
Other Current Assets, Total	-100K	-	-	-100K	-
Total Current Assets	1.6B	2.52B	2.32B	2.31B	3.07B
Gross Property Plant And Equipment	3.17B	3.34B	4.02B	4.74B	4.92B
Accumulated Depreciation	-1.58B	-1.77B	-2.19B	-2.57B	-2.62B
Net Property Plant And Equipment	1.59B	1.57B	1.83B	2.17B	2.3B
Long-term Investments	10.3M	14.1M	81.7M	83.6M	83.6M
Goodwill	3.61B	3.52B	4.12B	4.52B	4.55B
Other Intangibles, Total	918M	825M	896M	919M	796M
Deferred Tax Assets Long-Term	44M	76.6M	90.9M	75.7M	93.8M
Other Long-Term Assets, Total	44.2M	42.5M	-	-	-
Total Assets	7.82B	8.58B	9.33B	10.08B	10.89B
Liabilities
Accounts Payable, Total	232M	279M	323M	347M	339M
Accrued Expenses, Total	609M	782M	860M	836M	823M
Short-term Borrowings	320M	16.9M	80.3M	78.5M	300K
Current Portion of Long-Term Debt	7.2M	102M	52.8M	6.7M	458M
Current Portion of Leases	128M	119M	121M	129M	143M
Current Income Taxes Payable	20.7M	84.3M	86M	34.7M	26.7M
Unearned Revenue Current, Total	116M	137M	163M	184M	193M
Other Current Liabilities	149M	177M	170M	156M	139M
Total Current Liabilities	1.58B	1.7B	1.86B	1.77B	2.12B
Long-Term Debt	2.65B	2.5B	2.08B	2.71B	2.89B
Long-Term Leases	440M	415M	418M	399M	436M
Pension & Other Post Retirement Benefits	75.3M	73.3M	75.5M	59.5M	66.2M
Deferred Tax Liability Non Current	124M	115M	124M	134M	110M
Other Non Current Liabilities	56.7M	56.9M	100M	155M	128M
Total Liabilities	4.92B	4.86B	4.66B	5.23B	5.75B
Common Stock, Total	1.8M	1.9M	1.9M	1.9M	1.9M
Retained Earnings	719M	1.31B	1.96B	2.33B	2.39B
Treasury Stock	-200K	-	-3.6M	-14.2M	-54.9M
Comprehensive Income and Other	2.12B	2.38B	2.68B	2.46B	2.74B
Total Common Equity	2.84B	3.69B	4.65B	4.78B	5.08B
Minority Interest	59.5M	26.1M	29.5M	68.9M	59.9M
Total Equity	2.9B	3.72B	4.68B	4.85B	5.14B
Total Liabilities And Equity	7.82B	8.58B	9.33B	10.08B	10.89B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	179M	191M	192M	193M	193M
ECS Total Common Shares Outstanding	179M	191M	192M	193M	193M
Book Value / Share	10.27	14.1	18.98	21.8	21.14
Tangible Book Value	-1.69B	-659M	-363M	-661M	-270M
Tangible Book Value Per Share	-15.02	-8.69	-7.09	-6.46	-6.58
Total Debt	3.54B	3.15B	2.75B	3.33B	3.93B
Net Debt	3.24B	2.24B	2.24B	2.83B	2.7B
Debt Equivalent of Unfunded Proj. Benefit Obligation	75.3M	73.3M	75.6M	59.5M	66.3M
Debt Equivalent Oper. Leases	-	134M	96.8M	107M	88M
Minority Interest, Total (Incl. Fin. Div)	59.5M	26.1M	29.5M	68.9M	59.9M
Equity Method Investments, Total	5.3M	5.6M	6.2M	5.2M	5.3M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	81.9M	182M	193M	174M	157M
Land - (BS)	750M	784M	994M	1.28B	1.45B
Machinery, Total	1.56B	1.58B	1.94B	2.27B	2.38B
Full Time Employees	47.43K	51.52K	57.99K	61.38K	61.8K
Accumulated Allowance for Doubtful Accounts (Supple)	43.1M	44.9M	55.1M	57.9M	63.3M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	195M	539M	783M	610M	310M
Depreciation & Amortization - CF	357M	389M	429M	476M	522M
Amortization of Goodwill and Intangible Assets - (CF)	100M	103M	97.6M	104M	99.3M
Depreciation & Amortization, Total	457M	492M	526M	580M	621M
Amortization of Deferred Charges, Total - (CF)	2.3M	4.1M	7.3M	3.8M	4.7M
(Gain) Loss From Sale Of Asset	500K	-700K	100K	-141M	1.8M
Asset Writedown & Restructuring Costs	38.7M	36.9M	21.9M	41.7M	72.8M
(Income) Loss On Equity Investments - (CF)	-600K	-1.7M	-2M	-900K	-400K
Stock-Based Compensation (CF)	15.7M	16.5M	22.2M	22.9M	23.3M
Other Operating Activities, Total	25.8M	186M	157M	-11.7M	49M
Change In Accounts Receivable	-136M	-192M	-196M	47.5M	-43.4M
Change In Inventories	-12.9M	-77.7M	2.8M	8.6M	11M
Change In Accounts Payable	36.8M	132M	85.6M	20.1M	-41.3M
Change in Unearned Revenues	13.7M	20.4M	26.3M	21.1M	10.2M
Change In Deferred Taxes	-9.5M	-6.3M	-6.3M	-7.5M	-
Change in Other Net Operating Assets	51.2M	75.3M	82M	-58.6M	-1.3M
Cash from Operations	678M	1.22B	1.51B	1.14B	1.02B
Capital Expenditure	-280M	-311M	-458M	-576M	-478M
Sale of Property, Plant, and Equipment	5.4M	5.2M	24.8M	14.9M	6.4M
Cash Acquisitions	-171M	-177M	-533M	-430M	-158M
Divestitures	-	-	-	215M	7.3M
Sale (Purchase) of Intangible assets	-44.3M	-44.7M	-62M	-84.1M	-72M
Investment in Marketable and Equity Securities, Total	100K	-100K	-8.4M	1.5M	1.9M
Other Investing Activities, Total	-50.2M	2.6M	1.6M	2.6M	11.5M
Cash from Investing	-540M	-525M	-1.03B	-856M	-681M
Long-Term Debt Issued, Total	295M	946M	826M	634M	638M
Total Debt Issued	295M	946M	826M	634M	638M
Long-Term Debt Repaid, Total	-445M	-1.46B	-1.43B	-249M	-270M
Total Debt Repaid	-445M	-1.46B	-1.43B	-249M	-270M
Issuance of Common Stock	321M	564M	35.8M	14.6M	602M
Repurchase of Common Stock	-300M	-	-3.6M	-433M	-238M
Common Dividends Paid	-120M	-36.3M	-166M	-228M	-234M
Common & Preferred Stock Dividends Paid	-120M	-36.3M	-166M	-228M	-234M
Other Financing Activities, Total	-93.4M	-67.9M	-169M	-49.7M	-83.5M
Cash from Financing	-342M	-48.6M	-910M	-311M	414M
Foreign Exchange Rate Adjustments	4.1M	-33.9M	39.1M	-800K	-12.7M
Miscellaneous Cash Flow Adjustments	-100K	-	100K	-100K	100K
Net Change in Cash	-200M	616M	-396M	-31.8M	738M
Supplemental Items
Cash Interest Paid	93.3M	67.8M	169M	49.4M	82.2M
Cash Income Tax Paid (Refund)	95M	94M	297M	296M	140M
Levered Free Cash Flow	434M	793M	866M	501M	512M
Unlevered Free Cash Flow	492M	853M	918M	554M	584M
Change In Net Working Capital	42.1M	-33.1M	54.3M	61.4M	57.6M
Net Debt Issued / Repaid	-150M	-509M	-607M	385M	368M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	3.8	6.89	9.44	5.85	4.27
Return on Total Capital	4.63	8.49	11.82	7.28	5.2
Return On Equity %	6.95	16.34	18.66	12.72	6.16
Return on Common Equity	5.28	15.48	17.95	12.32	5.2
Margin Analysis
Gross Profit Margin %	20.4	25.97	28.49	22.74	21.1
SG&A Margin	0.02	0.01	0.19	0.21	0.2
EBITDA Margin %	17.59	23.42	26.02	20.15	18.22
EBITA Margin %	12.19	18.52	21.58	15.1	12.53
EBIT Margin %	10	16.63	20.13	13.54	11.01
Income From Continuing Operations Margin %	4.28	9.94	11.66	9.03	4.72
Net Income Margin %	4.28	9.92	11.65	9.09	4.76
Net Avail. For Common Margin %	3.19	9.29	11.14	8.65	3.94
Normalized Net Income Margin	4.96	9.16	11.57	7.27	5.91
Levered Free Cash Flow Margin	9.51	14.58	12.89	7.46	7.86
Unlevered Free Cash Flow Margin	10.78	15.69	13.66	8.26	8.97
Asset Turnover
Asset Turnover	0.61	0.66	0.75	0.69	0.62
Fixed Assets Turnover	3.49	3.43	3.95	3.36	2.92
Receivables Turnover (Average Receivables)	4.89	4.96	5.2	4.92	4.79
Inventory Turnover (Average Inventory)	49.86	34.08	30.87	34.6	36.12
Short Term Liquidity
Current Ratio	1.01	1.48	1.25	1.31	1.45
Quick Ratio	0.94	1.36	1.13	1.18	1.34
Operating Cash Flow to Current Liabilities	0.43	0.72	0.81	0.64	0.48
Days Sales Outstanding (Average Receivables)	74.64	73.85	70.16	74.25	76.26
Days Outstanding Inventory (Average Inventory)	7.32	10.74	11.82	10.55	10.11
Average Days Payable Outstanding	23.2	22.76	22.87	23.63	24.41
Cash Conversion Cycle (Average Days)	58.76	61.83	59.11	61.17	61.95
Long Term Solvency
Total Debt/Equity	122.21	84.89	58.88	68.55	76.43
Total Debt / Total Capital	55	45.91	37.06	40.67	43.32
LT Debt/Equity	106.51	78.5	53.46	64.15	64.73
Long-Term Debt / Total Capital	47.93	42.46	33.65	38.06	36.69
Total Liabilities / Total Assets	62.95	56.66	49.88	51.89	52.82
EBIT / Interest Expense	4.73	8.78	14.34	9.92	5.81
EBITDA / Interest Expense	9.47	13.56	19.92	16.26	10.85
(EBITDA - Capex) / Interest Expense	6.56	10.54	15.07	9.97	6.97
Total Debt / EBITDA	3.88	2.26	1.47	2.23	2.93
Net Debt / EBITDA	3.55	1.61	1.19	1.9	2.02
Total Debt / (EBITDA - Capex)